Histiocytes, represent the cells of the mononuclear phagocyte system (MPS) that can give rise to histiocytoses when they accumulate pathogenically in tissues due to dysregulation of proliferation or ...

The histiocytoses are a group of rare disorders that involve an abnormal accumulation of a specific cell type (the histiocyte) in various organs. Histiocytes are mainly derived from the bone marrow, ...

The cells seen on the fine-needle aspiration sample were consistent with a histiocytic origin. The gross appearance of the lesion along with the marked cellular homogeneity of the fine-needle ...

bGeorge Washington University, Washington, DC, USA and Attending Physicians in the Departments of Hematology–Oncology and Pathology, respectively, at the Children's National Medical Center, Washington ...

Kikuchi-Fujimoto disease (KFD) or histiocytic necrotising lymphadenitis is a rare entity, occurring most commonly in young Asian adults. KFD is characterised by fever with tender lymph node ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

Chronic histiocytic intervillositis (CHI) is a rare placental disorder associated with adverse pregnancy outcomes and high recurrence rates in subsequent pregnancies. We discuss a case of CHI ...

A 57-year-old woman with no known comorbidities presented to our dermatology clinic with a 6-month history of asymptomatic lesions on her upper back and upper limbs. Examination revealed well-defined, ...

Ensartinib hydrochloride is under clinical development by Betta Pharmaceuticals and currently in Phase II for Sarcomas.

The Social Security Administration (SSA) said on Monday that it will include additional conditions that can be part of its compassionate allowances, part of an approach to speed applications for ...

A 50-year-old man was diagnosed with leprosy on pre-immigration screening in the Philippines and was prescribed oral dapsone and rifampin. He immigrated to Canada 1 month later and discontinued ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...